Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 21,333 | 33,514 | 18,138 | 18,096 | 13,149 |
| Cost of Goods | 438 | 396 | 819 | 1,394 | 1,013 |
| Gross Profit | 20,895 | 33,118 | 17,319 | 16,702 | 12,136 |
| Operating Expenses | 68,442 | 73,833 | 65,494 | 60,362 | 51,550 |
| Operating Income | -47,109 | -40,319 | -47,356 | -43,266 | -39,401 |
| Interest Expense | 6,801 | 6,758 | 6,509 | 6,467 | 3,093 |
| Other Income | 459 | 788 | 1,000 | 1,088 | 1,147 |
| Pre-tax Income | -53,451 | -46,289 | -52,865 | -48,645 | -41,347 |
| Income Tax | 44 | 137 | 66 | 2 | 20 |
| Net Income Continuous | -53,495 | -46,426 | -52,931 | -48,647 | -41,367 |
| Net Income | $-53,495 | $-46,426 | $-52,931 | $-48,647 | $-41,367 |
| EPS Basic Total Ops | -10.94 | -9.45 | -11.69 | -11.24 | -10.05 |
| EPS Basic Continuous Ops | -10.92 | -9.50 | -11.73 | -11.33 | -9.99 |
| EPS Diluted Total Ops | -10.94 | -9.45 | -11.69 | -11.24 | -10.05 |
| EPS Diluted Continuous Ops | -10.92 | -9.50 | -11.73 | -11.33 | -9.99 |
| EBITDA(a) | $-44,227 | $-37,997 | $-45,190 | $-41,267 | $-37,627 |